Aquentium Announces Plans to Open Laser Therapy Clinics in USA
Lake Elsinore, CA, Nov 16, 2012 (WORLD STOCK WIRE via COMTEX) --
Aquentium, Inc. (OTCQB: AQNM) a diversified publicly traded company that is dedicated to bringing emerging technologies to companies and countries throughout the world.is pleased to announce that the company is planning on opening laser therapy clinics throughout the United States utilizing patented FDA approved technology that delivers low level laser therapy for individuals suffering from all types of pain.
Low-level laser therapy (LLLT), also called photobiomodulation, refers to the use of red-beam or near-infrared lasers with a wavelength between 600 and 1000 nm and Watts from 5 to 500 milliwatts. This is in contrast to surgical lasers that typically use 300 Watts. Low-level laser energy that is applied to acupuncture points on the body may be referred to as "laser acupuncture."
When applied to the skin, low level lasers produce no sensation and do not burn the skin. Because of the low absorption by human skin, it is hypothesized that the laser light can penetrate deeply into the tissues where it has a photobiostimulative effect. The exact mechanism of its effect is unknown; hypotheses have included improved cellular repair and stimulation of the immune, lymphatic, and vascular systems.
"Low back pain will affect 75-85% of all Americans at some point during their lifetime and the worldwide market for pain management continues to grow at a staggering rate. We believe our company will have a positive impact for individuals suffering from pain," stated Aquentium CEO Mark Taggatz.
LLLT has been proposed as a treatment of carpal tunnel syndrome, painful musculoskeletal disorders such as temporomandibular joint dysfunction and low back pain, soft tissue injuries, tendinopathies, and osteoarthritis. LLLT has been used outside the US to treat oral mucositis associated with radiation and chemotherapy, stimulate healing of chronic wounds, treat nerve injuries, and as an adjunct to antituberculosis drug treatment.
Deep Tissue Laser Therapy accelerates your body's own natural healing process through photo-bio-stimulation. Laser therapy is effective in treating chronic conditions, acute conditions and post surgical pain.
Our therapeutic laser offers a safe, often effective, easily utilized primary or adjunctive therapy that is relatively cost effective to the patient. Laser therapy can be a viable part of the multi-faceted approach often needed to bring relief to the millions of chronic low back pain sufferers that are present in offices, clinics, and hospitals.
Aquentium is a diversified publicly traded company (AQNM) that is dedicated to bringing emerging technologies to companies and countries throughout the world. The company's business includes healthcare, alternative energy (waste-to-energy, solar, wind), construction, water treatment, non-chemical (ozone) sanitation equipment, re-deployable / emergency housing, and engineering and architectural services.
Certain statements in this news release may contain "forward- looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. There can be no assurance that such forward-looking statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.
Mark Taggatz, CEO
571 Crane Street
Lake Elsinore, CA 92530
Note: The following news is from Aquentium, Inc., and World Stock Wire, Inc. is not liable for the contents of this news.
[ Back To TMCnet.com's Homepage ]